Correlation Between 23Andme Holding and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and VistaGen Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and VistaGen Therapeutics.
Diversification Opportunities for 23Andme Holding and VistaGen Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and VistaGen is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and VistaGen Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the VistaGen Therapeutics. In addition to that, 23Andme Holding is 2.84 times more volatile than VistaGen Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.19 per unit of volatility. If you would invest 322.00 in VistaGen Therapeutics on September 3, 2024 and sell it today you would lose (38.00) from holding VistaGen Therapeutics or give up 11.8% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. VistaGen Therapeutics
Performance |
Timeline |
23Andme Holding |
VistaGen Therapeutics |
23Andme Holding and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and VistaGen Therapeutics
The main advantage of trading using opposite 23Andme Holding and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
VistaGen Therapeutics vs. DiaMedica Therapeutics | VistaGen Therapeutics vs. Lyra Therapeutics | VistaGen Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |